Table 1. Demographic data, preoperative laboratory variables, and perioperative features of the patients.
| Variables | Group 1 (n=55) | Group 2 (n=24) | p-value |
|---|---|---|---|
| Age (years) | 60.8±8.7 | 62.2±10.3 | 0.237 |
| Male gender, n (%) | 44 (80%) | 21 (87.5%) | 0.422 |
| Diabetes mellitus, n (%) | 16 (29.1%) | 9 (37.5%) | 0.460 |
| Hypertension, n (%) | 30 (54.5%) | 17 (70.8%) | 0.175 |
| BMI, kg/m 2 | 27.9±3.4 | 28.3±3.3 | 0.934 |
| Smoking, n (%) | 31 (56.4%) | 16 (66.7%) | 0.391 |
| Hyperlipidemia, n (%) | 33 (60%) | 19 (79.2%) | 0.163 |
| Ejection fraction (%) | 55 (30–67) | 55 (35–65) | 0.338 |
| ASA use, n (%) | 30 (54.5%) | 16 (66.6%) | 0.315 |
| ACEI/ARB use, n (%) | 33 (67.3%) | 16 (66.6%) | 0.574 |
| White blood cell (103/μL) | 8.5 (4.4–14.8) | 8.8 (4.8–16.6) | 0.498 |
| Hemoglobin (mg/dL) | 13.5±1.9 | 13.7±1.4 | 0.143 |
| Platelet (103/μL) | 259.9±62.6 | 261±72.7 | 0.216 |
| Neutrophil (103/μL) | 4.1 (1.3–15.1) | 4.8 (1.3–18.8) | 0.085 |
| Lymphocyte (103/μL) | 1.5±0.5 | 1.3±0.8 | 0.122 |
| NLR | 2.5 (0.9–9.3) | 4.2 (1.4–10.9) | 0.037 |
| BUN | 16 (9–37) | 18 (11–35) | 0.217 |
| Creatinine (mg/dL) | 0.92±0.2 | 1.18±0.24 | <0.001 |
| CRP (mg/dL) | 14.4±3.9 | 16.7±4.5 | 0.290 |
| Syndecan-1 | 63.7 (7.4–253.5) | 91.1 (42.8–620.6) | 0.001 |
| Total perfusion time | 96.7±20.9 | 109±29 | 0.038 |
| Cross-clamp time | 72.1±20.5 | 70.6±23.2 | 0.287 |
| Number of distal anastomoses | 3 (16) | 3 (2–6) | 0.935 |
| Packed blood products (units) | 7 (4–9) | 9 (4–13) | <0.001 |
| Inotropic support, n (%) | 13 (23.6%) | 14 (58.3%) | 0.003 |
ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; ASA: acetylsalicylic acid; BMI: body mass index; CRP: C-reactive protein; BUN: blood urea nitrogen; NLR: neutrophil to lymphocyte ratio.